To identify the possible relationship between ZEB2‐AS1 expression and clinicopathological parameters in HNSCC, these patients were stratified into subgroups with high (n = 35) or low (n = 36) ZEB2‐AS1 expression when the median of ZEB2‐AS1 expression was utilized as cut‐off. The gene discussed is ZEB2; the disease is head and neck squamous cell carcinoma.